To the best of our knowledge, this is the first report which clearly showed blockade of AT1 signaling could prevent, although partially, the chronic deterioration of LV function induced by DM and addition of an MR antagonist had a further cardioprotective effect. The gene discussed is NR3C2; the disease is diabetes mellitus.